Evaluation of internet-based cognitive-behavioral therapy blended with sessions for depression in young adults

Not Applicable

• Conditions: Major depressive disorder in young adults; Mental and Behavioural Disorders

• Registration Number: ISRCTN12316538
• Lead Sponsor: Pennsylvania State University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-07-25
• Last Update Posted: 15 August 2022
• Study Completion: 2025-08-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Have access to a computer and/or mobile phone with an internet connection and data plan allowing 90 min spent on treatment per week
2. Fluent in the English language in terms of speaking, listening, reading, and writing
3. Aged 18-19 years
4. Presence of depressive symptoms as measured by a score =10 on the QIDS -17-SR
5. Fulfill DSM-5 Criteria for a major depressive episode
6. Depression is deemed the primary concern
7. Those currently taking antidepressants, central stimulants, and/or neuroleptics, will be accepted, if no change in dosage at least 6 weeks prior to study participation

Exclusion Criteria

1. Unable to consent, or actively confirm study participation
2. Ongoing/prior (CBT) treatment within the last 6 months
3. Significant suicidal ideation and/or history of previous suicide attempt
4. Judged to have problem/disorder that warrants more intensive in- person mental health and/or medical treatment (i.e., alcohol, substance use, and/or eating disorder, meets diagnostic criteria for psychotic disorders)
5. Judged to have other current severe problems require other actions at first hand
6. Lack of access to computer and/or mobile phone with an internet connection and sufficient data plan
7. Has ever been diagnosed with autism spectrum disorder and/or Attention Deficit Hyperactivity

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depressive symptoms measured using the Quick Inventory of Depressive Symptomatology in adolescents (QIDS-A17-SR) at baseline and 10 weeks (post-treatment)